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ABSTRACT  
An improved condensation of substituted chalcones 1a-g with hydrazine hydrate and formic acid in 2-methoxyethanol to afford 
new series of 4,5-dihydro-pyrazole-1-carbaldehyde derivatives 2a-g. Clean reaction conditions, simple workup procedure and 
short  reaction  time  giving  high  yields  of  product  are  notable  advantages  of  method.  All  newly  synthesized  compounds 
characterized by chemical test, spectral and elemental analysis. Further, all newly synthesized compounds were screened for their 
antimicrobial activity. Most of these title compounds exhibited potent activity. 
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1. INTRODUCTION 
Numerous  pyrazolines  type  compounds  have  found  to  exhibit  bioactivities
1,2  which  has  excellent  role  in  many 
pharmaceutical,  agrochemical  and  dystuff  research
3,4.  Pyrazolines  derivatives  with  a  phenyl  group  at  5-position 
possess  good  flim-forming  properties,  exhibit  excellent  characteristics  of  blue  photoluminescence  and 
electroluminescence
5.   Moreover pyrazolines are extensively useful synthons in organic chemistry and also important 
in the development of theory in heterocyclic chemistry. These compounds are also well known for their pronounced 
biological  activities  including  antimicrobial
5-7,  antitumor
8,  immunosuppressive
9,  anti-inflammatory
10,  anticancer
11, 
antidiabetic
12,  antiamoebic
13,  anticonvulsant
14,  antidepressant
15,  anesthetic
16,  estrogen  receptor  agonists
17  and 
cyclooxygenase inhibitor
18 properties. 
Synthesis of bicyclic pyrazoline derivatives were reported by condensation of 2,6-diarylidenecyclohexanones 
with  hydrazine  hydrate
19.  Acetone  and  acetophenones  on  base  catalyzed  condensation  with  substituted  aldehyde 
affords ʱ,β-unsaturated carbonyl compound which on treatment with hydrazine hydrate and formic acid yielded a 2-
pyrazoline
20. In view of these observations; it was thought worthwhile to synthesize some new different substituted 
pyrazoline  derivatives  by  reacting  chalcones  with  hydrazine  hydrate  and  formic  acid  in  2-methoxyethanol  as  an 
alternative  reaction  solvent  and  to  evaluate  them  for    antimicrobial  activity  against  Bacillus  subtilis  (Bs), 
Staphylococcus aureus (Sa), Candida albicans (Ca) and Aspergillus flavus (Af).  
 
2. RESULTS AND DISCUSSION 
In continuation of our work on different methodology in organic synthesis
21 and studies on some new bioactive 
compounds  and  their  heterocycles
22,  herein  we  report  synthesis  of  some  new  series  of  4,5-dihydro-pyrazole-1-
carbaldehyde derivatives by condensation of chalcones with hydrazine hydrate and formic acid in 2-methoxyethanol 
as an alternative reaction solvent.  
The  starting  chalcones  1a-g  were  prepared  by  classical  aldol  condensation  involving  base-catalyzed 
condensation  of  the  desired  carbonyl  compounds  followed  by  dehydration  forming  ʱ,β-unsaturated  carbonyl 
compounds. Synthesis of 4,5-dihydro-pyrazole-1-carbaldehyde were attempted by reacting ʱ,β-unsaturated carbonyl 
compounds (chalcones) with hydrazine hydrate and formic acid in presence of 2-methoxyethanol as solvent (Scheme-
1). Recently the formation of 2-pyrazoline was reported by the reaction of chalcones with hydrazine hydrate take place 
in various conditions using ethanol
23, acetic acid
24, formic acid
20, or pyridine
25 as solvent. However, many of these 
reported procedures have one or more disadvantages such as use of expensive catalyst, low selectivity, harsh reaction 
conditions, low yield, relatively long reaction time and environmental concern. After some preliminary observation we 
found that 2-methoxyethanol as an efficient reaction medium in terms of clean reaction conditions, not expensive, 
short reaction time giving high yields of desired product. In view of these results, we turned our attention towards 
variety substituted chalcones. In all cases, reaction proceeds efficiently in high yields using 2-methoxyethanol (Table-
3). The formation of products were assumed to proceed through the Micheal-type addition of hydrazine to activated 
double bond followed by intramolecular cyclization with the elimination of water molecule
26.  
The formation of chalcones 1a-g was confirmed by IR spectra, absence of a band around 1710-1720 cm
-1 due 
to the ketonic C=O stretch and the appearance of characteristic band near 1655 cm
-1 and near 1610 cm
-1 due to ʱ,β-
unsaturated carbonyl group and ν (C=C) respectively. In 
1H NMR spectrum of chalcones two doublet in range at ʴ 
6.86 (H-ʱ, J = 16.5 HZ) and ʴ 7.32 (H-β, J = 16.5 HZ) suggested the presence of olefin protons at ʱ,β-position to the 
carbonyl group. The IR spectrum of newly synthesized 2-pyrazolines 2a-g showed a strong band for carbonyl group 
near 1635 cm
-1 and band at 1577 cm
-1 due to C=N. In the 
1H NMR spectra, an ABX pattern was observed for HA, HB 
and HX proton which appear as pair of doublets near ʴ 3.20, 3.72 and 5.42 ppm. Trans olefin proton appears asPakistan Journal of Chemistry 2012 
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doublets near ʴ 6.85 and 7.14 ppm with J = 16 HZ. The singlet of CHO appeared at ʴ 8.92 ppm which conforms the N-
H of 2-pyrazoline replaced by N-CHO group. This also conforms on the basis of silver mirror test
27. 
The  results  of  antimicrobial  screening  data  are  given  in  Table  4.  In  comparison  with  reference  drugs, 
compounds 2e, 2f and 2g showed effective activity against all tested microbes. Compounds 2f and 2g showed near to 
par activity against  Candida albicans. Only compound 2f  showed potent activity against  Aspergillus flavus than 
standard fluconazole fungicide. Moreover compound 2f showed stronger activity against Staphylococcus aureus than 
reference streptomycin drug. The remaining compounds 2a-d displayed moderate antimicrobial activity. On the other 
hand compound 2a and 2b are inactive against Bacillus subtilis and Candida albicans. Results show that presence of 
halogen with hydroxy and methoxy substituent in basic pyrazole nucleus exhibits potent antimicrobial activity against 
various pathogens. 
 
3. CONCLUSION 
In summary, we have developed simple and easy procedure for synthesis of some novel 4,5-dihydro-pyrazole-1-
carbaldehyde derivative by condensation of chalcones with hydrazine hydrate and formic acid in 2-methoxyethanol as 
efficient and alternative reaction solvent. The advantages of present protocol are simplicity of operation, high yields of 
products and avoidance of expensive catalyst and usage of volatile organic solvent.  
 The preliminary in vitro antimicrobial screening of this series revealed that compounds 2e, 2f and 2g showed 
potent  activity  when  compared  with  standard  drug.  Therefore,  the  present  study  is  useful  drug  in  medicinal 
investigation against bacterial and fungal diseases.  
 
4. EXPERIMENTAL 
Melting points were determined in an open capillary tube and are uncorrected. IR spectra were recorded in KBr on a 
Perkin-Elmer spectrometer. 
1H NMR spectra were recorded on a Gemini 300-MHZ instrument in DMSO as solvent 
and TMS as an internal standard. The mass spectra were recorded on EISHIMADZU-GC-MS spectrometer. Elemental 
analyses were performed on a Perkin-Elmer 240 CHN elemental analyzer.    
 
4.1 General Procedure for synthesis of chalcones 1a-g 
To a mixture of different substituted benzaldehyde 1 (0.02 mol) and acetone 2 (0.01 mol) in ethanol,  10 % aqueous 
sodium hydroxide (10 ml) was added drop by drop with constant stirring at 0-5 
0C. After complete addition of NaOH 
solution, the reaction mixture left to stand in ice bath for 20 min. Then obtained yellow coloured solid was filtered 
washed with cold water and crystallized from ethanol to give the corresponding chalcones derivative. The physical 
data of synthesized chalcones are given in Table-1.  
 
Table-1: Physical Data Of Synthesized Products (la-g) 
Product  R  R1  R2  R3  Yeild(%)  M.P (
OC)  (Reported) 
1a  OH  H  H  H  80  110-113  (112)
28 
1b  H  H  OCH3  H  84  117-119  (118)
29 
1c  H  OCH3  OH  H  82  124-126  (124)
30 
1d  H  OC2H5  OH  H  79  138-140  (139)
31 
1e  H  OCH3  OH  Br  86  145-147  (145)
32 
1f  OH  Br  H  Br  83  157-159  ---- 
1g  OH  I  H  I  88  132-135  ---- 
 
4.2 1,5-Bis-(3,5-dibromo-2-hydroxy-phenyl)-penta-1,4-dien-3-one.1f  
IR (KBr): 3236 (OH), 1656 (C=O), 1608 (C=C) cm
-1. 
1H NMR (300 MHZ, DMSO) ʴ 6.86 (d, J = 16.5 HZ, 2H, Hʱ), ʴ 
7.31 (d, J = 16.5 HZ, 2H, Hβ), ʴ 12.21 (s, 2H, OH), ʴ 7.14-7.88 (m, 4H, Ar-H). MS m/z: 582 (M
+). Anal. Cacld for 
C17H10O3Br4: C, 35.05; H, 1.71; X (Br), 54.98. Found: C, 33.08; H, 1.75; X (Br), 55.02.   
 
4.3 1,5-Bis-(2-hydroxy-3,5-diiodo-phenyl)-penta-1,4-dien-3-one.1g: IR (KBr)  
3232 (OH), 1652 (C=O), 1610 (C=C) cm
-1. 
1H NMR (300 MHZ, DMSO) ʴ 6.89 (d, J = 16.5 HZ, 2H, Hʱ), ʴ 7.34 (d, J = 
16.5 HZ, 2H, Hβ), ʴ 12.26 (s, 2H, OH), ʴ 7.14-7.82 (m, 4H, Ar-H). MS m/z: 770 (M
+). Anal. Cacld for C17H10O3I4: C, 
26.49; H, 1.29; X (I), 65.97. C, 26.52; H, 1.31; X (I), 66.01. 
 
4.4 Typical procedure for synthesis of 4,5-dihydro-pyrazole-1-carbaldehyde. 2a-g 
A mixture of 1a (0.01 mol) hydrazine hydrate (0.02 mol) and formic acid (2ml) was dissolved in 2-methoxyethanol 
(10 ml). The reaction mixture was refluxed for period as shown in Table-2. The progress of reaction was monitored by 
TLC. After completion, reaction solution get cooled to room temperature and poured into crushed ice, obtained crude 
product was filtered washed with cold water and recrystallized from mixture of ethanol: dioxane to give the product 
2a-g. Similarly, other analogues of this were synthesized by using same procedure. Vibhute et, al 2012 
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Table-2: Physical Data Of Newly Synthesized 4.5-dihydro-pyrazole-1-carbaldehyde derivatives (2a-g) 
Product  R  R1  R2  R3  Time(h)  Yeild(%)  M.P (
OC) 
2a  OH  H  H  H  3  78  129-131 
2b  H  H  OCH3  H  4  86  133-135 
2c  H  OCH3  OH  H  3.5  84  141-143 
2d  H  OC2H5  OH  H  4  83  147-149 
2e  H  OCH3  OH  Br  3.5  80  154-156 
2f  OH  Br  H  Br  3  88  169-171 
2g  OH  I  H  I  4  91  158-160 
 
The progress of reaction was monitored by TLC. After completion, reaction solution get cooled to room temperature 
and poured into crushed ice, obtained crude product was filtered washed with cold water and recrystallized from 
mixture of ethanol: dioxane to give the product 2a-g. Similarly, other analogues of this were synthesized by using 
same procedure. 
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Scheme-1: Synthesis of 4,5-dihydro-pyrazole-1-carbaldehyde 2a-g 
 
4.5 5-(2-Hydroxy-phenyl)-3-[2-(2-hydroxy-phenyl)-vinyl]-4,5-dihydro-pyrazole-1-carbaldehyde.2a  
IR (KBr): 3373 (OH), 1628 (C=O), 1578 (C=N) cm
-1. 
1H NMR (300 MHZ, DMSO) ʴ 3.20 (dd, J = 5.0, 17.8 HZ, 1H, 
HA), ʴ 3.71 (dd, J = 12.0, 17.8 HZ, 1H, HB), ʴ 5.42 (dd, J = 5.1, 12.1 HZ, 1H, HX), ʴ 6.83 (d, J = 16.2 HZ, 1H, Hʱ), ʴ 
7.21 (d, J = 16.2 HZ, 1H, Hβ), ʴ 7.12-7.68 (m, 8H, Ar-H), ʴ 8.92 (s, 1H, CHO), 11.8 (s, 2H, two OH). 
13CNMR 
(DMSO) 162.48 (C=O), 156.19 (2C, of two Ar-OH), 144.72 (C=N), 138.24 (Cβ, C=C double bond), 137.23 (C, Ar-C), 
135.18 (C, Ar-C) 132.72 (2CH, of two Ar-C), 130.50 (2CH, of two Ar-C), 128.65 (2CH, of two Ar-C), 120.48 (2CH, 
of  two  Ar-C)  118.12  (Cʱ,  C=C  double  bond),  50.57  (-CH),  39.44  (-CH2).  MS  m/z  308  (M
+).  Anal.  Cacld  for 
C18H16O3N2: C, 70.12; H, 5.19. Found: C, 70.16; H, 5.22.  
 
4.6 5-(4-Methoxy-phenyl)-3-[2-(4-methoxy-phenyl)-vinyl]-4,5-dihydro-pyrazole-1-carbaldehyde (2b) 
IR (KBr): 1626 (C=O), 1572 (C=N) cm
-1. 
1H NMR (300 MHZ, DMSO) ʴ 3.82 (s, 6H, two OCH3), ʴ 3.21 (dd, J = 5.1, 
17.9 HZ, 1H, HA), ʴ 3.73 (dd, J = 12.2, 17.8 HZ, 1H, HB), ʴ 5.44 (dd, J = 5.1, 12.2 HZ, 1H, HX), ʴ 6.81 (d, J = 16.2 HZ, 
1H, Hʱ), ʴ 7.18 (d, J = 16.2 HZ, 1H, Hβ), ʴ 7.25-7.81 (m, 8H, Ar-H), ʴ 8.90 (s, 1H, CHO). 
13CNMR (DMSO) 165.58 
(2C of two para Ar-ome), 163.22 (C=O), 144.88 (C=N), 138.26 (Cβ of C=C double bond), 137.18 (C, Ar-C), 135.26 
(C, Ar-C), 131.43 (4CH of four Ar-C), 118.14 (Cʱ of C=C double bond), 116.13 (4CH of four Ar-C), 58.42 (2C, of 
two OCH3) 51.13 (-CH), 37.80 (-CH2),. MS m/z: 336 (M
+). Anal. Cacl for C20H20O3N2: C, 71.42; H, 5.95. Found: C, 
71.40; H, 5.92. Pakistan Journal of Chemistry 2012 
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4.7 5-(4-Hydroxy-3-methoxy-phenyl)-3-[2-(4-hydroxy-3-methoxy-phenyl)-vinyl]-4,5-dihydro-pyrazole-1-
carbaldehyde.2c 
IR (KBr): 3368 (OH), 1635 (C=O), 1577 (C=N) cm
-1. 
1H NMR (300 MHZ, DMSO) ʴ 3.8 (s, 6H, two OCH3), ʴ 3.23 
(dd, J = 5.1, 17.9 HZ,  1H, HA), ʴ 3.71 (dd, J = 12.1, 17.8 HZ,  1H, HB), ʴ 5.42 (dd, J = 5.1, 12.2 HZ, 1H, HX), ʴ 6.82 (d, 
J = 16 HZ, 1H, Hʱ), ʴ 7.14 (d, J = 16 HZ, 1H, Hβ), ʴ 7.28-7.76 (m, 6H, Ar-H), ʴ 8.93 (s, 1H, CHO), ʴ 10.73 (s, 2H, two 
OH). 
13CNMR (DMSO) 165.52 (2C of two Ar-ome), 162.25 (C=O), 156.21 (2C of two Ar-OH), 145.13 (C=N), 137.16 
(C, Ar-C), 135.20 (C, Ar-C), 138.26 (Cβ of C=C double bond), 121.87 (2CH, of two Ar-C), 118.38 (2CH, of two Ar-
C), 118.13 (Cʱ of C=C double bond), 114.27 (2CH of two Ar-C), 58.45 (2C of two OCH3), 50.41 (-CH), 38.37 (-CH2). 
MS m/z: 368 (M
+). Anal. Cacl for C20H20O5N2: C, 65.21; H, 5.43. Found: C, 65.18; H, 5.40. 
 
4.8 5-(3-Ethoxy-4-hydroxy-phenyl)-3-[2-(3-ethoxy-4-hydroxy-phenyl)-vinyl]-4,5-dihydro-pyrazole-1-
carbaldehyde.2d 
 IR (KBr): 3372 (OH), 1628 (C=O), 1574 (C=N) cm
-1. 
1H NMR (300 MHZ, DMSO) ʴ 1.38 (t, 6H, two CH3), ʴ 3.89 (q, 
4H, two OCH2), ʴ 3.22 (dd, J = 5.2, 17.9 HZ,1H, HA), ʴ 3.76 (dd, J = 12.2, 17.9 HZ,  1H, HB), ʴ 5.48 (dd, J = 5.2, 12.2 
HZ,  1H, HX), ʴ 6.79 (d, J = 16 HZ, 1H, Hʱ), ʴ 7.12 (d, J = 16 HZ, 1H, Hβ), ʴ 7.22-7.79 (m, 6H, Ar-H), ʴ 8.92 (s, 1H, 
CHO), ʴ 10.68 (s, 2H, two OH). 
13CNMR (DMSO) 164.88 (2C, of two Ar-OEt), 162.78 (C=O), 156.23 (2C, of two Ar-
OH), 145.22 (C=N), 137.18 (C, Ar-C), 135.16 (C, Ar-C), 138.24 (Cβ of C=C double bond), 121.92 (2CH, of two Ar-
C), 118.43 (2CH, of two Ar-C),  118.15 (Cʱ of C=C double bond), 114.32 (2CH, of two Ar-C) 51.17 (-CH), 38.33 (-
CH2, ring), 58.52 (2C of two OCH2), 16 (2C, of two CH3). MS m/z: 396 (M
+). Anal. Cacl for C22H24O5N2: C, 66.66; H, 
5.05. Found: C, 66.68; H, 5.08. 
 
4.9 5-(3-Bromo-4-hydroxy-5-methoxy-phenyl)-3-[2-(3-bromo-4-hydroxy-5-methoxy-phenyl)-vinyl]-4,5-
dihydro-pyrazole-1-carbaldehyde.2e 
 IR (KBr): 3366 (OH), 1632 (C=O), 1576 (C=N) cm
-1. 
1H NMR (300 MHZ, DMSO) ʴ 3.86 (s, 6H, two OCH3), ʴ 3.24 
(dd, J = 5.2, 17.9 HZ, 1H, HA), ʴ 3.71 (dd, J = 12.1, 17.8 HZ, 1H, HB), ʴ 5.47 (dd, J = 5.2, 12.1 HZ,   1H, HX), ʴ 6.82 (d, 
J = 16 HZ, 1H, Hʱ), ʴ 7.14 (d, J = 16 HZ, 1H, Hβ), ʴ 7.26-7.81 (m, 4H, Ar-H), ʴ 8.95 (s, 1H, CHO), ʴ 10.64 (s, 2H, 
OH).
 13CNMR (DMSO) 165.58 (2C of two Ar-ome), 156.29 (2C of two Ar-OH), 162.88 (C=O), 145.51 (C=N), 138.35 
(Cβ of C=C double bond), 137.14 (C of Ar-C), 135.12 (C of Ar-C), 125.51 (2CH of two Ar-C), 118.24 (Cʱ of C=C 
double bond), 119.52 (2C of two Ar-Br), 113.78 (2CH of two Ar-C), 58.49 (2C of two -OCH3), 51.25 (-CH), 38.26 (-
CH2). MS m/z: 526 (M
+). Anal. Cacl for C20H18O5N2Br2: C, 45.62; H, 3.42; X (Br), 34.22. Found: C, 45.59; H, 3.40; X 
(Br), 34.18. 
 
4.10 5-(3,5-Dibromo-2-hydroxy-phenyl)-3-[2-(3,5-dibromo-2-hydroxy-phenyl)-vinyl]-4,5-dihydro-pyrazole-1-
carbaldehyde.2f  
IR (KBr): 3371 (OH), 1630 (C=O), 1573 (C=N) cm
-1. 
1H NMR (300 MHZ, DMSO) ʴ 3.23 (dd, J = 5.0, 17.8 HZ, 1H, 
HA), ʴ 3.70 (dd, J = 12.0, 17.8 HZ,  1H, HB), ʴ 5.46 (dd, J = 5.1, 12.1 HZ,  1H, HX), ʴ 6.85 (d, J = 16 HZ, 1H, Hʱ), ʴ 
7.12 (d, J = 16 HZ, 1H, Hβ), 7.25-7.83 (m, 4H, Ar-H), ʴ 8.92 (s, 1H, CHO), ʴ 12.0 (s, 2H, two OH). 
13CNMR (DMSO) 
163.21 (C=O), 156.29 (2C of two Ar-OH), 144.97 (C=N), 138.28 (Cβ of C=C double bond), 137.24 (C of Ar-C), 
135.27 (C of Ar-C), 130.74 (2CH of two Ar-C), 129.61 (2CH of twoAr-C), 119.48 (2C of two Ar-Br), 118.18 (Cʱ of  
C=C  double  bond),  114.08  (2C  of  two  Ar-Br),  51.32  (-CH),  37.88  (-CH2).    MS  m/z:  624  (M
+).  Anal.  Cacl  for 
C18H12O3N2Br4: C, 34.61; H, 1.92; X (Br), 51.28. Found: C, 34.63; H, 1.95; X (Br), 51.30. 
 
4.11 5-(2-Hydroxy-3,5-diiodo-phenyl)-3-[2-(2-hydroxy-3,5-diiodo-phenyl)-vinyl]-4,5-dihydro-pyrazole-1-
carbaldehyde.2g 
IR (KBr): 3373 (OH), 1635 (C=O), 1573 (C=N) cm
-1. 
1H NMR (300 MHZ, DMSO) ʴ 3.23 (dd, J = 5.1, 17.9 HZ,   1H, 
HA), ʴ 3.67 (dd, J = 12.1, 17.8 HZ, 1H, HB), ʴ 5.44 (dd, J = 5.1, 12.2 HZ,  1H, HX), ʴ 6.87 (d, J = 16 HZ, 1H, Hʱ), ʴ 7.12 
(d, J = 16 HZ, 1H, Hβ), 7.22-7.81 (m, 4H, Ar-H), ʴ 8.93 (s, 1H, CHO), ʴ 12.1 (s, 2H, two OH). 
13CNMR (DMSO) 
163.27 (C=O), 156.24 (2C of two Ar-OH), 145.08 (C=N), 138.32 (Cβ of C=C double bond), 137.26 (C of Ar-C), 
135.22 (C of Ar-C), 130.57 (2CH of two Ar-C), 118.24 (Cʱ of C=C double bond) 112.36 (2CH, of two Ar-C), 88.17 
(4C of four Ar-I), 51.37 (-CH), 37.96 (-CH2). MS m/z: 812 (M
+). Anal. Cacl for C18H12O3N2I4: C, 26.60; H, 1.47; X 
(I), 62.56. Found: C, 26.63; H, 1.49; X (I), 62.58 
 
4.12 Antimicrobial Assay 
The antibacterial activities of the synthesized compounds (2a-g) were determined by agar well diffusion method
33. 
The compounds were evaluated for antibacterial activity against Bacillus subtilis [MTCC 2063] and Staphylococcus 
aureus  [MTCC  2901].  The  antifungal  activity  performed  against  Aspergillus  flavus  [MTCC  2501]  and  Candida 
albicans  [MTCC  183]  were  procured  from  Institute  of  Microbial Technology  (IMTech),  Chandigarh,  India. The 
antibiotic streptomycin (25µ/mL) and fluconazole used as reference drug for antibacterial and antifungal activity, 
respectively. Dimethyl sulphoxide (1%, DMSO) used a control without compound. Vibhute et, al 2012 
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Table-3: Effect of solvent on synthesis of 5-(2-Hydroxy-3,5-diiodo-phenyl)-3-[2-(2-hydroxy-3,5-diiodo-phenyl)-vinyl]-4,5-
dihydro-pyrazole-1-carbaldehyde : 2g 
Entry  Solvent  Time (h)  Yield (%) 
1  Ethanol  14  70 
2  Acetic acid  16  65 
3  Formic acid  18  68 
4  DMF  12  75 
5  2-Methoxyethanol  04  91 
 
Table-4: Antimicrobial screening of some new 4,5-dihydro-pyrozole-1-carbaldehyde 
Entry  Zone of inhibition (mm) 
  Af  Ca  Bs  Sa 
2a  12  15  --  13 
2b  17  --  15  12 
2c  21  19  18  17 
2d  23  21  19  19 
2e  26  24  28  26 
2f  28  26  26  30 
2g  26  26  28  26 
Reference 1  26  28  NA  NA 
Reference 2  NA  NA  30  28 
Reference 1 = Fluconazole 
Reference 2 = Streptomycin 
NA= Not Applicable 
 
The culture strains of bacteria were maintained on nutrient agar slant at 37 ± 0.5 
0C for 24 h. The antibacterial activity 
was evaluated using nutrient agar plate seeded with 0.1 mL of respective bacterial culture strain suspension prepared 
in sterile saline (0.85%) of 10
5 CFU/mL dilutions. The wells of 6 mm diameter were filled with 0.1 mL of compound 
solution at fixed concentration 25 µ/mL separately for each bacterial strain. All plates were incubated at 37 ± 0.5 
0C 
for 24 h. Zone of inhibition were noted in mm, Table-4.  
For antifungal activity, all culture strains of fungi maintained on potato dextrose agar (PDA) slant at 27 ± 0.2 
0C for 24-48 h, until sporulation. Spore of strains were transferred into 5 mL of sterile distilled water containing 1% 
Tween-80 (to suspend the spore properly). The spores were counted by haemocytometer (10
6 CFU/mL). Sterile PDA 
plate  was prepared  containing  2%  agar;  0.1  mL  of  each fungal  spore  suspension  was  spread  on  each plate  and 
incubated at 27± 0.2 
0C for 12 h. After incubation well prepared using sterile cork borer and each agar well was filled 
with 0.1 mL of compound solution at fixed concentration 25 µ/mL. The plates were kept in refrigerator for 20 min for 
diffusion and then incubated at 27± 0.2 
0C for 7 days except Candida albicans. After incubation, zone of inhibition of 
compounds were measured in mm along with standard, Table-4.  
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